EL, C., R, L., K, K., K, H., M, B., MT, B., . . . BK, C. (2025). Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors. Journal for immunotherapy of cancer, 13(4), . https://doi.org/10.1136/jitc-2024-011049
Chicago Style (17th ed.) CitationEL, Chang, et al. "Consensus Disease Definitions for Ophthalmic Immune-related Adverse Events of Immune Checkpoint Inhibitors." Journal for Immunotherapy of Cancer 13, no. 4 (2025). https://doi.org/10.1136/jitc-2024-011049.
MLA (9th ed.) CitationEL, Chang, et al. "Consensus Disease Definitions for Ophthalmic Immune-related Adverse Events of Immune Checkpoint Inhibitors." Journal for Immunotherapy of Cancer, vol. 13, no. 4, 2025, https://doi.org/10.1136/jitc-2024-011049.
Warning: These citations may not always be 100% accurate.
